In promising experiments, phage therapy forces bacteria into a no-win dilemma that lowers their defenses against drugs they’d ...

University of Liverpool researchers have engineered a library of strains that can be used to develop new antibacterial ...

The researchers estimated that, in 2050, the number of global deaths attributable to antimicrobial resistance could reach 1.9 ...

The first in-depth global analysis of antimicrobial resistance (AMR) forecasts over 39 million deaths from infections by 2050 ...

High-profile medicolegal cases in Mumbai and Bangalore shed light on healthcare challenges, emphasising the need for ...

Monoclonal antibodies—treatments developed by cloning a cell that makes an antibody—could help provide an answer to the ...

Acinetobacter baumannii has emerged in the last decades as a major cause of healthcare-associated infections and nosocomial outbreaks. Multidrug-resistant (MDR) A. baumannii is a rapidly emerging ...

Using engineered mice, researchers developed monoclonal antibodies that were effective against infection with A. baumannii.

A new global analysis warns that antibiotic resistance could lead to over 39 million deaths by 2050, highlighting an urgent ...

By 2050, around 2 million people — the majority aged over 70 — could die from drug-resistant infections each year.

MEMANT-3310 is under clinical development by Antabio and currently in Phase I for Acinetobacter Infections. According to GlobalData, Phase ...

University of Liverpool researchers have engineered a library of strains that can be used to develop new antibacterial ...